TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Manual muscle testing MMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Roland Morris Disability Questionnaire (RMDQ) for disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in consumption of home-delivered produce
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in usual consumption of fruits and vegetables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Pain assessment using Visual analogue scale (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain assessment using Short form McGill pain questionnaire (SF-MPQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain assessment using Leeds Assessment of Neuropathic Symptoms and Signs (LANSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain assessment using Pain catastrophizing scale (PCS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Regularization of the menstrual cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Prescription of lipid-lowering treatment at discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Nasal polyp recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients requiring hospital admission for hypoxia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Short-Version Spielberger State-Trait Anxiety Inventory (SSTAI) Score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Positive usability rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cumulative amount of AZD9833 excreted (CumAe)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative amount of AZD9833 excreted as a percentage of the radioactive dose administered (Cum%Ae)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: the need for additional antiemetics
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Overall Driving Performance Score (ODPS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in motion detection sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of menopause education
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: delta of vocabulary level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in rScO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in SrO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection rate of extrahepatic biliary structures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Brief pain inventory severity
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Proportion of tGFR values within 30% of nGFR values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Objective change measured by standardized cough stress test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective evaluation of vaginal atrophy/estrogenization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect on urinary symptoms and quality of life (IQOL Questionnaire)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Effect on urinary symptoms (Urogenital Distress Inventory 6 Questionnaire)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effect on urinary symptoms (Bladder voiding diary)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effect on urinary symptoms (MESA Questionnaire)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: FVC Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: FEV1 Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: FEV1/FVC Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: PEF Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: changes in avocatin b concentration in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Satisfaction With Assigned Treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Server-recorded Logins to Assigned Website
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Duration of Website Use (Days Since First Login)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Percentage Overlapping Coefficient - POC %
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Asymmetry index - ASIM %
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Activation Index - ATTIV %
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in TORQUE %
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in IMPACT %
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Lifestyle Category
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Modification of the Lipid Profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Multidimensional Anxiety Scale for Children-Second Edition (MASC 2)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Squat jump
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abalakov jump
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mindfulness Oriented Recovery Enhancement fidelity measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid MMEs on Timeline followback (TLFB)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: PEG (Pain, Enjoyment, General activity)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percent of Ki-67 positive cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in sickle cell disease medication adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ABC stroke-score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ABC bleeding-score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diagnostic accuracy of breath test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Radioactivity concentrations in focal and non-focal tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Life Birth Related Events
Endpoint domain: Mortality/survival
Primary endpoint: Late Abortion Related Events
Endpoint domain: Mortality/survival
Primary endpoint: Unfavourable clinical course during severe neutropenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of days till completed assessment of myocardial ischemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of participants that enroll in the study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of participants that complete 3 weeks of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants that show no serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Pain Score at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in clinician-rated child anxiety severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with wound healing complications
Endpoint domain: Adverse events/effects
Primary endpoint: SARS-CoV-2 Negativity by RT-PCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: COVID-19 symptoms improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety and tolerability indexes
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of Tourniquet Hypertension (TH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients requiring blood product infusion or platelet raising drugs due to bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Jamar hand dynamometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Upper Extremity Functional Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Agility Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3 Minutes Step Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mini Balance Evaluation Systems test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Carbon test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Manual coordination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of any other tumor
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of AOD specific PDC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glucose: time in range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of uncancelled dental appointments
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: accuracy of reduction of the fractured zygoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anti Xa activity (UI/ml)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ACT (seconds)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of objective response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: complete pathomorphological response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of swallowing disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Recovery (QoR-15) Scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Delirium Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Participant completion of the study
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in ACC-ASCVD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blastocyst aneuploidy rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Percentage of Participants with Histologically Confirmed Invasive Squamous Cell Carcinoma (SCC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of Heart Failure
Endpoint domain: Mortality/survival
Primary endpoint: Time of loss of consciousness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Depressive Symptomology
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in Anxious Symptomology
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in Sleep Symptomology
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Changes in Anhedonia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in coverage (Mothers)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in coverage (Newborns)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in completeness (Mothers)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in completeness (Newborns)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in postnatal Contacts (Mothers)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in postnatal Contacts (Newborns)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Ultrasound scan recordings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social Responsiveness Scale, SRS
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Area under the plasma curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in VOR Gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in VOR Phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Liver inflammation and fibrosis measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Left Ventricular Posterior Wall Dimension (LVPWd)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Left Ventricular Septal Dimension (lVSd)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Feasibility of intravenous ExoFlo
Endpoint domain: Resource use
Primary endpoint: total recruitment rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: program completion rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Peri-implant soft tissue phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interactive Voice Response (IVR) -diary score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients responding to the treatment switch
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Longitudinal patient information
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exhaled particles analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive power of non-coding RNA patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose Limiting Toxicity (DLT) expression
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of monkeypox cases following interhuman exposures
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of monkeypox cases following zoonotic exposures
Endpoint domain: Mortality/survival
Primary endpoint: Adherence rate to outpatient RP sessions
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in monocular best corrected distance visual acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic Errors
Endpoint domain: Adverse events/effects
Primary endpoint: Change in small airway parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Circulating blood glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Circulating blood insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of correct response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean reaction time in milliseconds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Survival 30-days after surgery
Endpoint domain: Mortality/survival
Primary endpoint: Overall survival 1-year after surgery
Endpoint domain: Mortality/survival
Primary endpoint: PM2.5 levels in smoke
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Movement on a 10 point Frown Movement Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse Event (AE) or Serious Adverse Event (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: biomarker derivation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CTCAE v5.0 Toxicity Criteria
Endpoint domain: Adverse events/effects
Primary endpoint: EORTC QLQ C-30
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EORTC QLQ-HN35
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Oxygen delivery capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in trust from baseline to 12 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety in Care Encounters at 12 months
Endpoint domain: Adverse events/effects
Primary endpoint: Hemorrhage control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of caregivers who enroll in the GOLD program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Variation of intra abdominal pressure measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variation of gastric residue measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Measurement of abdominal circumference in centimeters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endoscopic response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in clinical outcome using the Oxford Shoulder Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in substance use scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tear monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Annual incidence rate of pneumothorax
Endpoint domain: Adverse events/effects
Primary endpoint: Mean change of Thiobarbituric acid reactive substances level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serological remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Articular remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Who Complete a 12-week Exercise Therapy Program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pain pressure measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in Six-minutes walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of occurrence of worsening renal function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Rates of discontinuation of- or intolerance to the used agent for RAAS inhibition
Endpoint domain: Adverse events/effects
Primary endpoint: Overall Response Rate (ORR) at cycle 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GCSI-DD change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: maternal fetal attachment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement of SCORAD Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in numerical rating scale for pain during movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of serum lactate in predicting acute flare of ulcerative colitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in appetite
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maintaining remission after discontinuation of anti-HER-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Lutathera® treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of antral cross sectional area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: percentage of patients with improvement of the principal infectious diagnosis by clinical assessment within 7 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: percentage of patients with improvement in Erythrocyte Sedimentation Rate (ESR) (where applicable) within 7 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients with improvement in C-Reactive Protein (CRP) (where applicable) within 7 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants Achieving SALT90 Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Serum concentration of insulin-like growth factor 1 (IGF-1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes